Reza Bahadori
Corporate Officer/Principal at The National Investment Banking Association
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| William Jordan | M | - |
The National Investment Banking Association
| - |
| Lynne Bolduc | F | - |
The National Investment Banking Association
| 13 years |
| Ronald M. Stein | M | 63 |
The National Investment Banking Association
| - |
| Leonard Demers | M | - |
The National Investment Banking Association
| - |
| Jayson Gitt | M | - |
The National Investment Banking Association
| 9 years |
| Robert Hackel | M | - |
The National Investment Banking Association
| 9 years |
| Andrea Cataneo | F | - |
The National Investment Banking Association
| 9 years |
| Emily Foshee | F | - |
The National Investment Banking Association
| - |
| Michael Scilia | M | - |
The National Investment Banking Association
| 13 years |
| Patrick Power | M | - |
The National Investment Banking Association
| - |
| Gerald Adler | M | - |
The National Investment Banking Association
| - |
| Ronald A. Davis | M | 82 |
The National Investment Banking Association
| - |
| Chester Leon Frederick Paulson | M | 87 |
The National Investment Banking Association
| - |
| Seth Farbman | M | 57 |
The National Investment Banking Association
| 9 years |
| Wesley C. Hayne | M | 72 |
The National Investment Banking Association
| - |
| George Paul Morris | M | 83 |
The National Investment Banking Association
| - |
| Brian Zucker | M | 62 |
The National Investment Banking Association
| - |
| Anthony Petrelli | M | 71 |
The National Investment Banking Association
| - |
| Vicki Dawn Edwardsbarone | F | 64 |
The National Investment Banking Association
| 14 years |
| Peter Goldstein | M | 61 |
The National Investment Banking Association
| - |
| James S. Cassel | M | 68 |
The National Investment Banking Association
| - |
| Mark Elenowitz | M | 54 |
The National Investment Banking Association
| 6 years |
| Nico Pronk | M | - |
The National Investment Banking Association
| - |
| Stephen W. Devanney | M | - |
The National Investment Banking Association
| - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Matthias C. Kurth | M | 68 |
Chemokine Therapeutics Corp.
 Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | 6 years |
| John Osth | M | 77 |
Chemokine Therapeutics Corp.
Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | 4 years |
| Michael Allen Evans | M | 64 |
Chemokine Therapeutics Corp.
Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | 3 years |
| Bernard Clinton Byrd | M | 61 |
Chemokine Therapeutics Corp.
Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | - |
| George M. Kowalchuk | M | 82 |
Chemokine Therapeutics Corp.
Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | - |
| Donald CK Wong | M | - |
Chemokine Therapeutics Corp.
Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 24 | 80.00% |
| Canada | 6 | 20.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Reza Bahadori
- Personal Network
